A review article on role of plecanatide drug in irritable bowel syndrome with constipation and chronic idiopathic constipation

Abstract

Plecanatide, a guanylate cyclase-C agonist, has emerged as a promising therapeutic option for gastrointestinal disorders, specifically irritable bowel syndrome with constipation and chronic idiopathic constipation. This review provides a concise analysis of plecanatide drug, covering their mechanisms of action, clinical efficacy, safety profile, and implications for patient care. The bulk drug form and tablet presentation both offer unique advantages in the treatment landscape. As research continues, plecanatide stands out for its targeted approach and favorable safety profile, presenting a valuable option for a diverse range of patients.